Follow
Vagolu Siva Krishna
Title
Cited by
Cited by
Year
Synthesis, antitubercular evaluation and molecular docking studies of phthalimide bearing 1, 2, 3-triazoles
PS Phatak, RD Bakale, ST Dhumal, LK Dahiwade, PB Choudhari, ...
Synthetic communications 49 (16), 2017-2028, 2019
592019
Usnic acid enaminone-coupled 1, 2, 3-triazoles as antibacterial and antitubercular agents
PK Bangalore, SK Vagolu, RK Bollikanda, DK Veeragoni, PC Choudante, ...
Journal of natural products 83 (1), 26-35, 2019
542019
Discovery and evaluation of novel Mycobacterium tuberculosis ketol-acid reductoisomerase inhibitors as therapeutic drug leads
VS Krishna, S Zheng, EM Rekha, LW Guddat, D Sriram
Journal of computer-aided molecular design 33, 357-366, 2019
532019
Synthesis and biological evaluation of 1H-pyrrolo [2, 3-d] pyrimidine-1, 2, 3-triazole derivatives as novel anti-tubercular agents
KS Raju, S AnkiReddy, G Sabitha, VS Krishna, D Sriram, KB Reddy, ...
Bioorganic & medicinal chemistry letters 29 (2), 284-290, 2019
502019
Novel benzimidazole-acrylonitrile hybrids and their derivatives: Design, synthesis and antimycobacterial activity
MM Sirim, VS Krishna, D Sriram, OU Tan
European Journal of Medicinal Chemistry 188, 112010, 2020
442020
Ultrasonication-ionic liquid synergy for the synthesis of new potent anti-tuberculosis 1, 2, 4-triazol-1-yl-pyrazole based spirooxindolopyrrolizidines
V Pogaku, VS Krishna, D Sriram, K Rangan, S Basavoju
Bioorganic & Medicinal Chemistry Letters 29 (13), 1682-1687, 2019
442019
1, 2, 3-Triazole-fused spirochromenes as potential anti-tubercular agents: Synthesis and biological evaluation
D Ashok, P Chiranjeevi, AV Kumar, M Sarasija, VS Krishna, D Sriram, ...
RSC advances 8 (30), 16997-17007, 2018
422018
Pyrazole–coumarin and pyrazole–quinoline chalcones as potential antitubercular agents
G Kumar, V Siva Krishna, D Sriram, SM Jachak
Archiv der Pharmazie 353 (8), 2000077, 2020
402020
Synthesis and biological evaluation of 2, 4, 5-trisubstituted thiazoles as antituberculosis agents effective against drug-resistant tuberculosis
UB Karale, VS Krishna, EV Krishna, AS Choudhari, M Shukla, ...
European Journal of Medicinal Chemistry 178, 315-328, 2019
392019
New N-phenylacetamide-incorporated 1, 2, 3-triazoles:[Et 3 NH][OAc]-mediated efficient synthesis and biological evaluation
SV Akolkar, AA Nagargoje, VS Krishna, D Sriram, JN Sangshetti, ...
RSC advances 9 (38), 22080-22091, 2019
382019
Design, Synthesis and Molecular Docking Studies of Novel Triazole‐Chromene Conjugates as Antitubercular, Antioxidant and Antifungal Agents
SP Khare, TR Deshmukh, JN Sangshetti, VS Krishna, D Sriram, ...
ChemistrySelect 3 (46), 13113-13122, 2018
382018
Design, synthesis, and biological evaluation of benzo [d] imidazole-2-carboxamides as new anti-TB agents
TM Dhameliya, KI Patel, R Tiwari, SK Vagolu, D Panda, D Sriram, ...
Bioorganic Chemistry 107, 104538, 2021
352021
Benzimidazoquinazolines as new potent anti-TB chemotypes: Design, synthesis, and biological evaluation
PS Jadhavar, KI Patel, TM Dhameliya, N Saha, MD Vaja, VS Krishna, ...
Bioorganic Chemistry 99, 103774, 2020
342020
A robust synthesis of functionalized 2H-indazoles via solid state melt reaction (SSMR) and their anti-tubercular activity
S Vidyacharan, C Adhikari, VS Krishna, RS Reshma, D Sriram, ...
Bioorganic & medicinal chemistry letters 27 (7), 1593-1597, 2017
342017
Anti-tubercular activity of novel class of spiropyrrolidine tethered indenoquinoxaline heterocyclic hybrids
N Arumugam, AI Almansour, RS Kumar, SI Alaqeel, VS Krishna, D Sriram
Bioorganic Chemistry 99, 103799, 2020
332020
Novel 1, 3, 4-oxadiazoles as antitubercular agents with limited activity against drug-resistant tuberculosis
VB Makane, VS Krishna, EV Krishna, M Shukla, B Mahizhaveni, S Misra, ...
Future Medicinal Chemistry 11 (6), 499-510, 2019
332019
Identification and development of benzoxazole derivatives as novel bacterial glutamate racemase inhibitors
P Malapati, VS Krishna, R Nallangi, RR Srilakshmi, D Sriram
European Journal of Medicinal Chemistry 145, 23-34, 2018
322018
Design and synthesis of new indanol-1, 2, 3-triazole derivatives as potent antitubercular and antimicrobial agents
PS Phatak, RD Bakale, RS Kulkarni, ST Dhumal, PP Dixit, VS Krishna, ...
Bioorganic & Medicinal Chemistry Letters 30 (22), 127579, 2020
312020
Design and synthesis of thiourea-based derivatives as Mycobacterium tuberculosis growth and enoyl acyl carrier protein reductase (InhA) inhibitors
ŞD Doğan, MG Gündüz, H Doğan, VS Krishna, C Lherbet, D Sriram
European Journal of Medicinal Chemistry 199, 112402, 2020
312020
Discovery of hydrazone containing thiadiazoles as Mycobacterium tuberculosis growth and enoyl acyl carrier protein reductase (InhA) inhibitors
H Doğan, ŞD Doğan, MG Gündüz, VS Krishna, C Lherbet, D Sriram, ...
European Journal of Medicinal Chemistry 188, 112035, 2020
312020
The system can't perform the operation now. Try again later.
Articles 1–20